Literature DB >> 27064641

A causal relationship between uric acid and diabetic macrovascular disease in Chinese type 2 diabetes patients: A Mendelian randomization analysis.

Dandan Yan1, Jie Wang1, Feng Jiang1, Rong Zhang1, Tao Wang1, Shiyun Wang1, Danfeng Peng1, Zhen He1, Haibing Chen1, Yuqian Bao1, Cheng Hu2, Weiping Jia1.   

Abstract

BACKGROUND: As the association between uric acid and macrovascular disease has been heavily debated, we aimed to confirm whether there is a causal relationship between uric acid and diabetic macrovascular disease through Mendelian randomization analysis.
METHODS: In 3207 type 2 diabetes patients, seventeen SNPs (single nucleotide polymorphisms) related to uric acid were genotyped. A weighted GRS (genetic risk score) was calculated using selected SNPs and the strength of their effects on uric acid levels. Diabetic macrovascular disease was diagnosed through vascular ultrasound, magnetic resonance imaging or other clinical evidence. Associations of diabetic macrovascular disease with uric acid and weighted GRS were evaluated separately.
RESULTS: In total participants and among females, the prevalence of diabetic macrovascular disease was significantly higher in hyperuricemic group than in normouricemic group, and uric acid was associated with diabetic macrovascular disease (OR=1.068, p=0.0349; OR=1.122, p=0.0158). The prevalence of diabetic macrovascular disease increased with the weighted GRS in a J-shaped manner for the females. The weighted GRS was positively correlated with uric acid in total population, male patients and female patients (β=0.203, p<0.0001; β=0.255, p<0.0001; β=0.142, p<0.0001, respectively). The weighted GRS was significantly associated with diabetic macrovascular disease in female patients (OR=1.184, p=0.0039). Among females, the observed association between weighted GRS and diabetic macrovascular disease was greater than predicted.
CONCLUSIONS: Using the uric acid-related weighted GRS as an instrumental variable for Mendelian randomization analysis, our study provided an evidence for causal relationship between uric acid and diabetic macrovascular disease in Chinese females with type 2 diabetes mellitus.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic macrovascular disease; Genetic risk score; Mendelian randomization analysis; Single nucleotide polymorphism; Uric acid

Mesh:

Substances:

Year:  2016        PMID: 27064641     DOI: 10.1016/j.ijcard.2016.03.206

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update.

Authors:  Claudio Borghi; Justyna Domienik-Karłowicz; Andrzej Tykarski; Krystyna Widecka; Krzysztof J Filipiak; Miłosz J Jaguszewski; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 2.737

2.  Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population.

Authors:  Dan-Dan Yan; Jie Wang; Xu-Hong Hou; Yu-Qian Bao; Zhen-Lin Zhang; Cheng Hu; Wei-Ping Jia
Journal:  Acta Pharmacol Sin       Date:  2017-12-14       Impact factor: 6.150

Review 3.  Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.

Authors:  Avi Goldberg; Fernando Garcia-Arroyo; Fumihiko Sasai; Bernardo Rodriguez-Iturbe; Laura Gabriela Sanchez-Lozada; Miguel A Lanaspa; Richard J Johnson
Journal:  Am J Nephrol       Date:  2021-10-21       Impact factor: 4.605

Review 4.  Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.

Authors:  Xue Li; Xiangrui Meng; Maria Timofeeva; Ioanna Tzoulaki; Konstantinos K Tsilidis; John PA Ioannidis; Harry Campbell; Evropi Theodoratou
Journal:  BMJ       Date:  2017-06-07

Review 5.  Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.

Authors:  Thomas Bardin; Pascal Richette
Journal:  BMC Med       Date:  2017-07-03       Impact factor: 8.775

Review 6.  Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications.

Authors:  Qing Xiong; Jie Liu; Yancheng Xu
Journal:  Int J Endocrinol       Date:  2019-10-13       Impact factor: 3.257

7.  Vitamin D supplementation is associated with serum uric acid concentration in patients with prediabetes and hyperuricemia.

Authors:  Hataikarn Nimitphong; Sunee Saetung; La-Or Chailurkit; Suwannee Chanprasertyothin; Boonsong Ongphiphadhanakul
Journal:  J Clin Transl Endocrinol       Date:  2021-04-02

Review 8.  Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.

Authors:  Abutaleb Ahsan Ejaz; Takahiko Nakagawa; Mehmet Kanbay; Masanari Kuwabara; Ada Kumar; Fernando E Garcia Arroyo; Carlos Roncal-Jimenez; Fumihiko Sasai; Duk-Hee Kang; Thomas Jensen; Ana Andres Hernando; Bernardo Rodriguez-Iturbe; Gabriela Garcia; Dean R Tolan; Laura G Sanchez-Lozada; Miguel A Lanaspa; Richard J Johnson
Journal:  Semin Nephrol       Date:  2020-11       Impact factor: 5.299

Review 9.  Uric Acid and Hypertension: An Update With Recommendations.

Authors:  Laura G Sanchez-Lozada; Bernardo Rodriguez-Iturbe; Eric E Kelley; Takahiko Nakagawa; Magdalena Madero; Dan I Feig; Claudio Borghi; Federica Piani; Gabriel Cara-Fuentes; Petter Bjornstad; Miguel A Lanaspa; Richard J Johnson
Journal:  Am J Hypertens       Date:  2020-07-18       Impact factor: 3.080

10.  Relationship between Serum Uric Acid and Vascular Function and Structure Markers and Gender Difference in a Real-World Population of China-From Beijing Vascular Disease Patients Evaluation Study (BEST) Study.

Authors:  Huan Liu; Jinbo Liu; Hongwei Zhao; Yingyan Zhou; Lihong Li; Hongyu Wang
Journal:  J Atheroscler Thromb       Date:  2017-09-12       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.